PROM1 and ovarian carcinoma: It is noted that exposure of ovarian cancer cells to lipoplatin decreased aldehyde dehydrogenase and prominin-1 (also known as CD133) expression, which are markers of ovarian cancer stem cells and decreased spheroid growth and cell migration [65].